Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Shire plc: Continued Strong Product Sales Performance in Q3: On Track to Deliver Significant 2011 Earnings Growth
Date:10/28/2011
n and the inclusion of DERMAGRAFT, including the fair value adjustment for DERMAGRAFT inventories in Q3 2011.
R&D
% of % of product product Q3 2011 sales Q3 2010 sales $M $M R&D (US GAAP) 201.5 20% 197.9 25% Impairment of intangible assets (16.0) - Up-front payment to Acceleron - (45.0) Depreciation (5.6) (4.4) R&D (Non GAAP) 179.9 18% 148.5 19%
Non GAAP R&D was up $31.4 million, or 21%, due to growing investment in a number of targeted R&D programs, including Sanfilippo A and other early stage development programs, in addition to increased investment in new uses for VYVANSE. Non GAAP R&D in Q3 2011 also included expenditure on the development programs acquired with Movetis and ABH, neither of which were incurred in Q3 2010.
On a US GAAP basis, R&D costs in Q3 2011 also include an intangible asset impairment charge, and Q3 2010 included the up-front payment to Acceleron.
SG&A
% of % of product product Q3 2011 sales Q3 2010 sales $M $M SG&A (US GAAP) 452.1 44% 392.4 49% Intangible asset amortization (46.4) (31.2) Impairment of intangible assets - (42.7) Depreciation (16.7) (16.1) SG&A (Non GAAP) 389.0 38% 302.4 38%
Non GAAP SG&A increased by $86.6 million, or 29% as we continue to support the growth of our existing and newly launched products. Non GAAP SG&A in Q3 2011 included expenditure for ABH and Movetis which was not incurred in the same period in 2010.
On a US GAAP basis, SG&A costs in Q3 2010 included an impairment charge to write down the DAYTRANA intangible asset to its fair value less costs to sell following agreement to divest the product to Noven Pharmaceuticals Inc. ("Noven").
Reorganization costs
For the three months to September 30, 2011 Shire recorded reorganization costs of $5.0 million (Q3 2010: $9.7 million) relating to the transfer of manufacturing from its Owings Mills facility and the establish
'/>"/>
| SOURCE Shire plc Copyright©2010 PR Newswire. All rights reserved |
Related biology technology :
1. NHS Northamptonshire Chief Executive John Parkes Accepts Visiting Professorship
2. FDA Approves Shires FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE)
3. Shires Quarterly Revenues Grow by 25% to $1 Billion for the First Time
4. Shire Files Lawsuits Against Watson and Roxane for Infringement of VYVANSE(R) (lisdexamfetamine dimesylate) Patents
5. Shire Presents Data at ACMG for Fabry and Gaucher Patients Who Switched to Replagal® (agalsidase alfa) and VPRIV® (velaglucerase alfa for injection)
6. Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules as Adjunctive Treatment in Major Depressive Disorder
7. Shire plc: Continued Excellent Performance in Q3, Full Year Earnings Expectations Increased, New Value in Pipeline Emerging
8. Shire Announces Results of the Tender Offer for Movetis NV and Commencement of Squeeze-Out Tender Period
9. Reportlinker Adds Shire plc: PharmaVitae Profile
10. Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease
11. Shire plc - Statement re ProAmatine
Post Your Comments:
(Date:5/20/2013)... Oven Industries Inc. announces a new laboratory ... controller has many outstanding user-friendly benefits. Contained all in ... wall as a self-contained temperature control system, which has ... device unique, as well as highly convenient for users. ... be used universally, which allows the user to use ...
(Date:5/20/2013)... , May 20, 2013 MiMedx Group, Inc. ... and marketer of patent protected regenerative biomaterials and bioimplants ... has secured a revolving line of credit with Bank ... is secured by the Company,s accounts receivable and inventory, ... May 1, 2014. The facility will be used for ...
(Date:5/20/2013)... -- Today, at the American Psychiatric Association (APA) Meeting ... James McGough , M.D., M.S., principal investigator and ... Neuroscience and Human Behavior and David Geffen ... California Los Angeles (UCLA), and director of clinical teaching ... at UCLA, presented the results of a Phase I ...
(Date:5/20/2013)... 2013 (PSHR) Pacific Shore Holdings, Inc. a ... a broad range of product categories lines, today ... firm, BlueWater Advisory Group, to provide strategic counsel ... and to direct the company,s outreach and investor ... Matthew Mills , Pacific Shore Holdings, ...
Breaking Biology Technology:New Laboratory Temperature Controller by Oven Industries 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5Pacific Shore Holdings Retains Investor Relations Firm 2[0] New Laboratory Temperature Controller by Oven Industries[0] MiMedx Secures a $3.0 Million Revolving Line of Credit with Bank of America[0] Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS)[0] Pacific Shore Holdings Retains Investor Relations Firm
... good workers to Procter & Gambles manufacturing plant in Green ... and technology used by those workers is another matter. , ... Bounty and Puffs have increased 50 percent, with no machine ... companys Green Bay plant. The last time anybody built a ...
... Wis. -- The Congenital Heart Institute at ... are now utilizing VERICIS Cardiovascular Information System. VERCIS, developed ... images and is designed to improve patient care. , ... hospitals echocardiography labs, giving physicians network access to cardio ...
... Wisconsins biotechnology sector and other well-established biotech regions is ... News featuring Wisconsins biotech sector as Americas Third ... , ,The East and West Coasts are often regarded ... flourish, some believe Wisconsin is catching up. According to ...
Cached Biology Technology:To attract investment, convince manufacturers that regulatory reform is real 2To attract investment, convince manufacturers that regulatory reform is real 3Wisconsin's biotech industry recognized by national publication 2(Date:5/20/2013)... 2013) University of Minnesota Medical School researchers from ... with the University,s Brain Tumor Program, have developed a ... (MPNST) that allow them to discover new genes and ... research was published this week in the journal ... method, researchers in the lab of David Largaespada, Ph.D., ...
(Date:5/20/2013)... the effect of physical education (PE) on child weight, ... increasing the amount of time that elementary schoolchildren spent ... The study represents some of the first evidence of ... is forthcoming in the Journal of Health Economics ... can be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 , The ...
(Date:5/20/2013)... lungs of the planet, inhales carbon dioxide as it exudes ... parts that eventually fall to the ground to decompose or ... Until recently people believed much of the rain forest,s carbon ... the ocean. University of Washington research showed a decade ago ... left open the question of how that was possible, since ...
Breaking Biology News(10 mins):U of M researchers develop model for better testing, targeting of MPNST 2Gym class reduces probability of obesity, study finds for first time 2Amazon River exhales virtually all carbon taken up by rain forest 2Amazon River exhales virtually all carbon taken up by rain forest 3... -Philadelphia, Pa Two internationally recognized scientists with strong Philadelphia ... The award ceremony will be held at 5:30 p.m. on ... College of Physicians of Philadelphia, located at 19 South 22nd ... a Scottish chemist and philanthropist who had a love of ...
... craters they leave behind , F. Pacheco-Vazquez and J.C. ... It,s generally accepted that craters in the moons and ... some craters completely flat while others show central peaks? ... material appear to provide a solution to the long-standing ...
... informatics professionals, honors four leaders in biomedical and ... during AMIA,s Annual Symposium, Oct. 22-26, an event ... Washington Hilton over the coming week. The Signature ... the health sector have had significant, positive impact. ...
Cached Biology News:Philadelphia scientists to be honored with the John Scott Award 2Philadelphia scientists to be honored with the John Scott Award 3Crater shapes explained, how carnivorous plants bite, and doubts about faster-than-light neutrinos 2AMIA honors informatics professionals who are improving health, changing the world 2AMIA honors informatics professionals who are improving health, changing the world 3GFX PCR DNA,Gel Band Purif,100, 1 EA. Category: Nucleotide Sample Handling....
... Services are uniquely positioned to ... current competitive environment. Invitrogens experts ... express, purify, and characterize proteins ... Studies, Activity Assays, X-ray Crystallography, ...
Protein 3D structure prediction, via threading. Easy to use....
... Tray (3 per pack), 1. ... blot processing.Automated staining of Coomassie Blue ... nucleic acid analysis.Prepares blots for high ... control of protocol, solution, volume, and ...
Biology Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |